Trending Topic

Breast Cancer
29 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Endocrine therapy (ET) has changed the natural history of hormone receptor-positive (HR+) breast cancer (BC) and is the cornerstone of the treatment of HR+ BC. There are several ETs approved for the treatment of BC, including selective oestrogen receptor modulators (SERMs; tamoxifen), aromatase inhibitors (AIs; anastrazole, letrozole and exemestane) and selective oestrogen receptor degraders (SERDs; fulvestrant […]

Nancy Lin, SABCS 2021: Updated Results of the HER2CLIMB Study

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 14th 2021

Dr Nancy Lin (Dana-Farber Cancer Institute, Boston, MA, USA) discusses the updated results of the phase II HER2CLIMB study, which assessed tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2-positive metastatic breast cancer with brain metastases. These results were presented at the San Antonio Breast Cancer Symposium 2021.

Questions
1. What options are currently available to patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer and brain metastases who have disease progression after therapy with multiple HER2-targeted agents? 00:10-01:00
2. Could you give us a brief overview of the HER2CLIMB study and its unique features? 01:00-01:55
3. What were the efficacy and safety findings of the initial analysis of patients with brain metastases at baseline? 01:55-02:30
4. What have the updated findings taught us, and how will they inform clinical practice? 02:30-04:08
5. What questions remain unanswered about the combination of tucatinib, trastuzumab and capecitabine, and what further studies are planned? 04:08-05:22

Speaker Disclosure: Nancy Lin discloses study steering committee at AstraZeneca and research funding (to institution) from SeaGen, Pfizer and Genentech.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the San Antonio Breast Cancer Symposium 2021

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup